Literature DB >> 10686300

Endogenous corticotropin-releasing hormone inhibits conditioned-fear-induced vagal activation in the rat.

M J Nijsen1, G Croiset, M Diamant, R Stam, P J Kamphuis, A Bruijnzeel, D de Wied, V M Wiegant.   

Abstract

The role of the endogenous corticotropin-releasing hormone (CRH) system in the regulation of heart rate, PQ interval (a measure of vagal activity), gross activity and release of adrenocorticotropic hormone (ACTH), noradrenaline and adrenaline into the blood during conditioned fear was studied in freely moving rats. Intracerebroventricular (i.c.v.) infusion of alpha-helical CRH-(9-41) (10 microgram/3 microliter), a non-selective CRH receptor antagonist, under resting conditions had no significant effect on gross activity, heart rate and PQ interval, indicating that alpha-helical CRH at this dose was devoid of agonist effects. Conditioned fear was induced by 10 min forced exposure to a cage in which the rat had experienced footshocks (5x0.5 mAx3 s) 1 day before. Conditioned-fear rats showed freezing behaviour, associated with an increase in heart rate, PQ interval, noradrenaline and adrenaline, indicating that the conditioned-fear-induced cardiac effects were the result of coactivation of the sympathetic and parasympathetic nervous system. The i.c.v. pre-treatment of rats with alpha-helical CRH significantly reduced the conditioned-fear-induced tachycardiac and ACTH response, and enhanced the increase in PQ interval, without affecting the noradrenaline and adrenaline response. These results suggest that endogenous CRH reduces the vagal response to conditioned-fear stress in rats. To test this, rats were pre-treated with atropine methyl nitrate (0.3 mg/kg, subcutaneously; s.c.), a peripherally acting cholinergic receptor antagonist. This resulted in a complete blockade of the alpha-helical CRH-induced decrease in heart rate response and increase in PQ interval. From these findings, it is concluded that endogenous CRH in the brain inhibits vagal outflow induced by emotional stress.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10686300     DOI: 10.1016/s0014-2999(99)00870-5

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

1.  Facilitation of cardiac vagal activity by CRF-R1 antagonists during swim stress in rats.

Authors:  Susan K Wood; Robert E Verhoeven; Aaron Z Savit; Kenner C Rice; Peter S Fischbach; James H Woods
Journal:  Neuropsychopharmacology       Date:  2006-05-03       Impact factor: 7.853

Review 2.  Adrenomedullary, adrenocortical, and sympathoneural responses to stressors: a meta-analysis.

Authors:  David S Goldstein; Irwin J Kopin
Journal:  Endocr Regul       Date:  2008-09

Review 3.  Neuropeptide and steroid hormone mediators of neuroendocrine regulation.

Authors:  A L Heck; C C Crestani; A Fernández-Guasti; D O Larco; A Mayerhofer; C E Roselli
Journal:  J Neuroendocrinol       Date:  2018-08-07       Impact factor: 3.627

4.  Defensive freezing and its relation to approach-avoidance decision-making under threat.

Authors:  Felix H Klaassen; Leslie Held; Bernd Figner; Jill X O'Reilly; Floris Klumpers; Lycia D de Voogd; Karin Roelofs
Journal:  Sci Rep       Date:  2021-06-08       Impact factor: 4.379

Review 5.  Freeze for action: neurobiological mechanisms in animal and human freezing.

Authors:  Karin Roelofs
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-04-19       Impact factor: 6.237

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.